Evaluation of Body Composition, Psychosocial Factors, and Drug-Related Problems in Relation to Clinical Progression in Cancer Patients Receiving Immune Checkpoint Inhibitors
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 200
- 试验地点
- 1
- 主要终点
- Body composition evaluation
研究概览
简要总结
Evaluation of the effects of body composition, psychosocial factors, and drug-related problems on clinical progression (such as toxicity, treatment response, and quality of life) in cancer patients treated with immune checkpoint inhibitors
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Aged 18 years or older
- •Having undergone a CT scan (at the L3 level) prior to treatment
- •No severe mental disorder and able to communicate effectively
- •Provided written informed consent
排除标准
- •Did not provide written informed consent
- •Patients deemed unsuitable by the physician
结局指标
主要结局
Body composition evaluation
时间窗: Patient recruitment is planned to occur over a 6-month period. Each participant will be followed for a maximum duration of 6 months from the initiation of immunotherapy.
Body Composition Parameters Description: Muscle area, muscle index, muscle density, lean body mass, and combined indices derived from routine abdominal imaging at the L3 vertebral level. Unit of measure: cm², cm²/m², Hounsfield units (HU), kilograms. Tool: Routine clinical imaging analysis.
次要结局
- Cachexia and psychosocial factors evaluation(Throughout 6 months of follow-up.)
- Drug Related Problems(Throughout 6 months of follow-up.)
研究者
İzgi Bayraktar
PhD candidate
Hacettepe University